United States · FDA National Drug Code directory
Dapagliflozin and Metformin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-155_513bdf9f-774c-4f7f-935a-54d3885e80a4
- Product NDC
- 59651-155
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Dapagliflozin and Metformin hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260406
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPAGLIFLOZIN — 5 mg/1
- METFORMIN HYDROCHLORIDE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 400 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-155-04) · 59651-155-04
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-155-30) · 59651-155-30
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-155-60) · 59651-155-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →